Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min Han Tan

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
Plos Genetics|September 6, 2008
Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing responseJulie M Koeman, Ryan C Russell, Min-Han Tan, et al.
Oncotarget|October 6, 2017
Molecular characterization of circulating colorectal tumor cells defines genetic signatures for individualized cancer careSay Li Kong, Xingliang Liu, Nur-Afidah Mohamed Suhaimi, et al.
NPJ Precision Oncology|November 13, 2025
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian populationJing Yi Lee, Aya El Helali, Donavan Jia Jie Tan, et al.
Anticancer Research|December 6, 2015
Fumarate Hydratase-deficient Cell Line NCCFH1 as a New In Vitro Model of Hereditary Papillary Renal Cell Carcinoma Type 2Victoria Perrier-Trudova, Bernice Wong Huimin, Sarinya Kongpetch, et al.
Clinical Genitourinary Cancer|December 3, 2014
Characteristics of long-term and short-term survivors of metastatic renal cell carcinoma treated with targeted therapies: results from the International mRCC Database ConsortiumAndré P Fay, Wanling L Xie, Jae-Lyn Lee, et al.
European Urology|August 7, 2013
Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapyNils Kroeger, Toni K Choueiri, Jae-Lyn Lee, et al.
Cancer|May 23, 2013
Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteriaNils Kroeger, Wanling Xie, Jae-Lyn Lee, et al.
Cancer Research|October 20, 2004
Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotypeCarola J Haven, Viive M Howell, Paul H C Eilers, et al.
JCO Precision Oncology|June 21, 2024
Androgen Receptor Splice Variant 7 in Asian Patients With Metastatic Castration-Resistant Prostate CancerDaniel Ang, Johan Chan, Whee Sze Ong, et al.
European Urology|November 5, 2013
The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database ConsortiumFabio A B Schutz, Wanling Xie, Frede Donskov, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
Plos Genetics|September 6, 2008
Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing responseJulie M Koeman, Ryan C Russell, Min-Han Tan, et al.
Oncotarget|October 6, 2017
Molecular characterization of circulating colorectal tumor cells defines genetic signatures for individualized cancer careSay Li Kong, Xingliang Liu, Nur-Afidah Mohamed Suhaimi, et al.
NPJ Precision Oncology|November 13, 2025
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian populationJing Yi Lee, Aya El Helali, Donavan Jia Jie Tan, et al.
Anticancer Research|December 6, 2015
Fumarate Hydratase-deficient Cell Line NCCFH1 as a New In Vitro Model of Hereditary Papillary Renal Cell Carcinoma Type 2Victoria Perrier-Trudova, Bernice Wong Huimin, Sarinya Kongpetch, et al.
Clinical Genitourinary Cancer|December 3, 2014
Characteristics of long-term and short-term survivors of metastatic renal cell carcinoma treated with targeted therapies: results from the International mRCC Database ConsortiumAndré P Fay, Wanling L Xie, Jae-Lyn Lee, et al.
European Urology|August 7, 2013
Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapyNils Kroeger, Toni K Choueiri, Jae-Lyn Lee, et al.
Cancer|May 23, 2013
Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteriaNils Kroeger, Wanling Xie, Jae-Lyn Lee, et al.
Cancer Research|October 20, 2004
Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotypeCarola J Haven, Viive M Howell, Paul H C Eilers, et al.
JCO Precision Oncology|June 21, 2024
Androgen Receptor Splice Variant 7 in Asian Patients With Metastatic Castration-Resistant Prostate CancerDaniel Ang, Johan Chan, Whee Sze Ong, et al.
European Urology|November 5, 2013
The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database ConsortiumFabio A B Schutz, Wanling Xie, Frede Donskov, et al.
Pageof 15